GlaxoSmithKline's Volibris is a new endothelin receptor antagonist for the treatment of idiopathic (primary) pulmonary arterial hypertension, as well as PAH associated with connective tissue disease.
Ontario Public Drug Programs is asking pharmacists to be part of a pilot project for the next phase of MedsCheck, which is expected to begin in January 2009.
Calgary Co-operative Association Limited has made its first foray into the home health care market with the recent purchase of Home Health Care and Medical Supply Centre.
The AYC Pharmacy on Vancouver's downtown East Hastings Street has had its pharmacy license suspended indefinitely following an investigation by the College of Pharmacists of B.C.
